Company is launching DS Implants, harmonizing successful brands like Simplant, OSSIX, Atlantis and MIS.
Three signature workflows to provide dental professionals with a completely new way of practicing implantology and solutions from scan to crown that outperform expectations in efficiency, accuracy, esthetics, longevity and simplicity were introduced today by Dentsply Sirona. Additionally, the company has launched DS PrimeTaper, a self-tapping implant.
The dental manufacturer just announced the comprehensive restage of its implants business, including:
With a complete ecoystem of digital solutions and products – including well-known brands like Simplant, OSSIX, Axeos, Primescan, Atlantis and MIS – Dentsply Sirona is streamlining implant treatments for practice growth and consistent patient satisfaction.
Dentsply Sirona Implants is now presenting DS PrimeTaper, a self-tapping implant with a tapered design that can be inserted safely and easily. This enables long-term bone stability. The double thread allows the implant to be inserted quickly and safely. A simple drilling protocol, with only a few different drills, supports the workflow.
The company worked closely with the global implant key opinion leader community, and they have already started gaining experience with the product. Their reactions have been very positive:
Dan Butterman, DDS, from Centennial, Colorado, emphasizes the importance of a seamless workflow. “DS PrimeTaper represents the next step in implant dentistry. The digital-driven workflow results in higher accuracy, repeatability of processes, and time savings,” Butterman says. "My patients have better things to do than spending time in my office. Thanks to clearly defined processes and digital solutions, I can offer safer and faster treatment options which my patients appreciate. That's what efficiency is all about."
• Martin Wanendeya, DDS, from the United Kingdom, notes "DS PrimeTaper as a part of an integrated concept is different from what we knew before. In addition to reducing chair time and simplifying collaboration with my laboratory, Primescan for Atlantis suprastructures ensures esthetic predictability and a perfect fit.”
Seamless Concept for Transforming Digital Implant Dentistry
“Dentsply Sirona is about intelligent concepts that work intuitively and improve the predictability of treatment,” says Terri Dolan, DDS, Chief Clinical Officer at Dentsply Sirona. “Our goal is to enable clinicians, including both specialists and general practitioners, to focus on what they do best – creating healthy and beautiful smiles. We are confident that we are building a winning future in the area of implant solutions focused on the needs of our implant customers and their patients. Our connected and seamless concept for transforming digital implant dentistry is a first, essential step in this direction. Our vision for digital implant dentistry will be supported by a global clinical education program focused on end-to-end digital implant workflow solutions to achieve clinic, technical and practice excellence. The extensive curriculum is designed to build clinicians’ digital implant skills according to their level of experience and personal learning preferences.”
Updates from Dentsply Sirona World
Dentsply World 2021 is taking place this week in Las Vegas, Nevada.
In cooperation with the McGuire Institute (iMc), 2 levels of evidence will be covered: The basis is provided by a prospective, multicenter, clinical study evaluating the complete digital workflow including 10 private practice investigators and their referrals for a five-year follow-up.
In addition, an ambitious registry study has been initiated aiming to involve more than 500 clinicians, placing over 2500 implants for long-term follow-up. A key benefit of a registry study is to obtain long-term clinical data without being prescriptive or having a specific endpoint. Therefore, it’s a powerful tool to create scientific evidence and market insights from the daily use of the product by the clinician. Both the clinical trial and the registry will collect “Real World Evidence” which is now recognized by the FDA as being the standard in collecting data and is meaningful to clinicians and patients alike.